Literature DB >> 22785371

The association between severity of obstructive sleep apnea and prevalence of Hashimoto's thyroiditis.

Nujen Colak Bozkurt1, Basak Karbek, Erman Cakal, Hikmet Firat, Mustafa Ozbek, Tuncay Delibasi.   

Abstract

Obstructive sleep apnea (OSA) has long been suggested to increase the risk of development of autoimmune diseases. We investigated the prevalence of Hashimoto's thyroiditis (HT) in 245 euthyroid individuals, who were suspected of having OSA. After polysomnography, subjects were grouped according to apnea-hypopnea index (AHI) consecutively as controls (n=27F/32M, AHI<5), mild-OSA (n=22F/37M, 5≤AHI<15), moderate-OSA (n=23F/38M, 15≤AHI<30) and severe-OSA (n=30F/36M, AHI≥30). Diagnosis of HT based on thyroid ultrasound and positivity of serum anti-thyroglobulin (anti-TG) and anti-thyroid peroxidase (anti-TPO) antibodies. Hashimoto's thyroiditis was diagnosed in 32.2% of controls and in 46.8% of all OSA patients (p=0.03). Severe-OSA patients had the highest HT frequency (51.5%) compared to controls (p=0.02), mild-OSA (42.3%, p=0.03) and moderate-OSA (45.9%, p=0.05) groups. Forty-two of control subjects (71.2%) were negative for both of the anti-TPO and anti-TG, whereas 99 (53.2%) of OSA subjects were positive at least for one of them (p=0.01). HT was detected in 62% of females, 29% of males (p<0.001). Severe female OSA patients had the highest HT prevalence (73.3%), while male control subjects had the lowest (18.7%) among all groups (p<0.001). There was no significant correlation between thyroid volume and severity of OSA but isthmus thickness was significantly correlated to AHI (p<0.01, r=0.22). In conclusion, OSA patients presented higher HT prevalence parallel to severity of OSA, especially among women. These results may lead to further investigations about relation between OSA and auto-immune thyroiditis and to development of screening schemas for severe-OSA patients for early diagnosis of HT before development of hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22785371     DOI: 10.1507/endocrj.ej12-0106

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  8 in total

1.  Lack of association between OSAS and hypothyroidism.

Authors:  Turkan Mete; Yavuz Yalcin; Bulent Ciftci
Journal:  Endocrine       Date:  2013-06-26       Impact factor: 3.633

Review 2.  Impact of concomitant medications on obstructive sleep apnoea.

Authors:  Ingrid Jullian-Desayes; Bruno Revol; Elisa Chareyre; Philippe Camus; Céline Villier; Jean-Christian Borel; Jean-Louis Pepin; Marie Joyeux-Faure
Journal:  Br J Clin Pharmacol       Date:  2016-11-24       Impact factor: 4.335

3.  Lack of association between OSAS and hypothyroidism.

Authors:  Pierluigi Carratù; Silvano Dragonieri; Onofrio Resta
Journal:  Endocrine       Date:  2013-05-15       Impact factor: 3.633

4.  Hashimoto Thyroiditis as a Cause or Consequence of Obstructive Sleep Apnea.

Authors:  Ellen M S Xerfan; Anamaria S Facina; Monica L Andersen; Sergio Tufik; Jane Tomimori
Journal:  J Clin Sleep Med       Date:  2019-11-15       Impact factor: 4.062

5.  Relationship between obstructive sleep apnea syndrome and thyroid diseases.

Authors:  Turkan Mete; Yavuz Yalcin; Dilek Berker; Bulent Ciftci; Selma Guven Firat; Oya Topaloglu; Halise Cinar Yavuz; Serdar Guler
Journal:  Endocrine       Date:  2013-04-06       Impact factor: 3.633

6.  Thyroid Stimulating Hormone Is Increased in Hypertensive Patients with Obstructive Sleep Apnea.

Authors:  Nanfang Li; Mulalibieke Heizhati; Chao Sun; Suofeiya Abulikemu; Liang Shao; Xiaoguang Yao; Yingchun Wang; Jing Hong; Ling Zhou; Lei Wang; Yu Zhang; Weiwei Zhang
Journal:  Int J Endocrinol       Date:  2016-11-02       Impact factor: 3.257

7.  Sleep disturbance in alopecia areata: A cross-sectional study.

Authors:  Safoura Shakoei; Alireza Torabimirzaee; Zahra Saffarian; Robabeh Abedini
Journal:  Health Sci Rep       Date:  2022-04-01

8.  Characterization of genetic and phenotypic heterogeneity of obstructive sleep apnea using electronic health records.

Authors:  Olivia J Veatch; Christopher R Bauer; Brendan T Keenan; Navya S Josyula; Diego R Mazzotti; Kanika Bagai; Beth A Malow; Janet D Robishaw; Allan I Pack; Sarah A Pendergrass
Journal:  BMC Med Genomics       Date:  2020-07-25       Impact factor: 3.622

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.